CoRegen
Developer of a drug discovery platform intended to accelerate the development of new cancer treatments. The company's platform utilizes machine learning to identify and rank therapeutic targets, refin...
Valuation
$372M
Market implied
Share Price
N/A
Total Raised
$77.1M
Last Round
N/A